FDA issues milestone draft guidance on decentralized clinical trial design & implementation | Hogan Lovells

The U.S. Food and Drug Administration (FDA) has just published a highly-anticipated draft guidance on the implementation of decentralized clinical trials (DCTs) for drugs, biologics,...

Related Keywords

Robert Califf ,Office Of Medical ,Drug Omnibus Reform Act ,Remote Regulatory Assessments ,Health Technologies ,Remote Data Acquisition ,Leonard Sacks ,Medical Policy ,